BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12107727)

  • 1. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
    Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
    Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of locally expressed CTLA4-Ig in a pancreatic beta cell line on the accelerated graft rejection response induced by DST.
    Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Monden M; Uede T; Miyasaka M
    Transplant Proc; 2001; 33(1-2):552. PubMed ID: 11266954
    [No Abstract]   [Full Text] [Related]  

  • 3. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
    Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB
    J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
    Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
    Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
    Shirasugi N; Akiyama Y; Aramaki O; Shibutani S; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Niimi M
    Transplantation; 2003 May; 75(10):1636-9. PubMed ID: 12777848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival.
    Gainer AL; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
    Transplantation; 1997 Apr; 63(7):1017-21. PubMed ID: 9112357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
    Chahine AA; Yu M; McKernan MM; Stoeckert C; Lau HT
    Transplantation; 1995 May; 59(9):1313-8. PubMed ID: 7762068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C; Dai K; Tang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of CTLA4-Ig gene transfer on rejection of rat islet xenografts].
    Zhang J; Chen GH; Lu MQ; Weng JP; Yang Y; Cai CJ; Xu C; Li H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):159-61. PubMed ID: 18250031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CTLA4-Ig prevents corneal allograft rejection in mice].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
    O'Rourke RW; Kang SM; Lower JA; Feng S; Ascher NL; Baekkeskov S; Stock PG
    Transplantation; 2000 Apr; 69(7):1440-6. PubMed ID: 10798768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
    Fernandes JR; Duvivier-Kali VF; Keegan M; Hollister-Lock J; Omer A; Su S; Bonner-Weir S; Feng S; Lee JS; Mulligan RC; Weir GC
    Transpl Immunol; 2004 Nov; 13(3):191-200. PubMed ID: 15381202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of corneal allografts by CTLA4-Ig.
    Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
    Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs.
    Safley SA; Kapp JA; Weber CJ
    Cell Transplant; 2002; 11(7):695-705. PubMed ID: 12518896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.